Actively Recruiting

Phase Not Applicable
Age: 40Years +
All Genders
NCT05919342

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

Led by NHS Greater Glasgow and Clyde · Updated on 2023-08-04

3904

Participants Needed

7

Research Sites

521 weeks

Total Duration

On this page

Sponsors

N

NHS Greater Glasgow and Clyde

Lead Sponsor

U

University of Glasgow

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is an international prospective, multicentre, unblinded, randomised-controlled trial. The primary aim is to assess a targeted screening strategy to detect undiagnosed heart failure in high-risk patients.

CONDITIONS

Official Title

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 40 years or older
  • Able to provide informed consent
  • Have two or more of the following risk factors for heart failure:
    1. Coronary artery disease (previous heart attack, bypass surgery, angioplasty, or significant artery narrowing)
    2. Diagnosed diabetes (type 1 or type 2)
    3. Persistent or permanent atrial fibrillation
    4. Previous ischemic or embolic stroke
    5. Peripheral arterial disease with prior revascularization or significant artery narrowing
    6. Chronic kidney disease with reduced kidney function or high urine albumin
    7. Regular use of loop diuretics for more than 30 days
    8. Chronic obstructive pulmonary disease diagnosed by tests, specialist, CT scan, or treatment
Not Eligible

You will not qualify if you...

  • Unable to give informed consent due to significant cognitive impairment
  • Previously diagnosed with heart failure
  • Currently receiving renal replacement therapy
  • Considered unsuitable for the study by investigators due to other medical conditions affecting survival

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Not Yet Recruiting

2

University of British Columbia

Vancouver, British Columbia, Canada

Not Yet Recruiting

3

University of Montreal

Montreal, Quebec, Canada

Not Yet Recruiting

4

Rigshospitalet, Copenhagen University Hospital

Copenhagen, Denmark

Not Yet Recruiting

5

Karolinska University Hospital

Stockholm, Sweden

Not Yet Recruiting

6

Uppsala University

Uppsala, Sweden

Not Yet Recruiting

7

University of Glasgow

Glasgow, Scotland, United Kingdom, G12 8TD

Actively Recruiting

Loading map...

Research Team

M

Mark C Petrie, MbChB

CONTACT

K

Kieran F Docherty, MbChB

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here